罗非昔布
Rofecoxib
产品价格
| 产品编号 | 品牌 | 纯度规格 | 包装单位 | 单价(元) | 现货 |
| 3215635 | Sigma-Aldrich | ≥98% (HPLC) | 10 MG | 1021 | 请咨询 |
| 3215635 | Sigma-Aldrich | ≥98% (HPLC) | 50 MG | 4260 | 请咨询 |
| 3464589 | 翁江 | ≥98.0% | 100g | 1620 | 请咨询 |
| 3464589 | 翁江 | ≥98.0% | 25g | 1006 | 请咨询 |
| 3464589 | 翁江 | ≥98.0% | 5g | 525 | 请咨询 |
| 4006240 | TCI | ≥98% (HPLC) | 1G | 1630 | 请咨询 |
| 4006240 | TCI | ≥98% (HPLC) | 250MG | 588 | 请咨询 |
| 4056225 | Alfa Aesar | ≥98% (HPLC) | 250mg | 6940 | 请咨询 |
结构式
 |
基本信息
| Empirical Formula【经验(实验)分子式】 | C17H14O4S |
| Molecular weight | 314.36 |
| NACRES | NA.77 |
| Application【应用】 | Rofecoxib has been used in high performance bioaffinity chromatography. |
| Biochem/physiol Actions【生化/生理作用】 | Rofecoxib is derived from furanone and has the ability to cross human placenta. Along with anti-inflammatory action, it possesses analgesic and antipyretic properties. Cytosolic hepatic enzymes are responsible for the metabolism of rofecoxib. It is known to cause oligohydramnios and ductus arteriosus constrictions. Rofecoxib inhibits the action of CYP1A2 (cytochrome P450 family 1 subfamily A member 2). It might be associated with aseptic meningitis. Rofecoxib is known to ameliorate the risk of colorectal adenoma, but might contribute to toxicity. Rofecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor with >800-fold COX-2 selectivity in CHO cells expressing human COX-1 and COX-2. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to beige |
| solubility【溶解性】 | DMSO: 5 mg/mL, clear (warmed) |
| storage temp.【储存温度】 | 2-8℃ |
| InChI | 1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3 |
| InChI key | RZJQGNCSTQAWON-UHFFFAOYSA-N |
| packaging【包装】 | 10, 50 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |